Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Solid Tumor × IFL protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 70 Colonic Neoplasms 16 Neoplasm Metastasis 14 Rectal Neoplasms 13 Neoplasms 9 Stomach Neoplasms 6 Carcinoma, Non-Small-Cell Lung 4 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Gastrointestinal Neoplasms 3 Carcinoma, Renal Cell 3 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Carcinoma, Neuroendocrine 2 Breast Neoplasms 2 Adenocarcinoma 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Prostatic Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Adenocarcinoma Metastatic 1 Neuroendocrine Tumors 1 Metastatic Pancreatic Ductal Adenocarcinoma 1

Interventions

Injections 22 toripalimab 13 pembrolizumab 13 tislelizumab 11 Gemcitabine 8 Cisplatin 7 Carboplatin 7 atezolizumab 6 spartalizumab 5 Paclitaxel 5 Oxaliplatin 5 Leucovorin 5 Irinotecan 5 Fluorouracil 5 Bevacizumab 5 Nivolumab 4 Capecitabine 4 trastuzumab deruxtecan 3 sintilimab 3 olaparib 3 Drug Therapy 3 Docetaxel 3 Cyclophosphamide 3 Cetuximab 3 Albumin-Bound Paclitaxel 3 penpulimab 2 niraparib 2 lenvatinib 2 glumetinib 2 fludarabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05147350 2025-12-05

MINOTAUR

Debiopharm International SA

Phase 1 Terminated

38 enrolled 17 charts

Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡